Home Cart Sign in  
Chemical Structure| 1315355-93-1 Chemical Structure| 1315355-93-1

Structure of NG25
CAS No.: 1315355-93-1

Chemical Structure| 1315355-93-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NG25 effectively inhibits both TAK1 and MAP4K2, displaying IC50s of 149 nM and 21.7 nM, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of NG25

CAS No. :1315355-93-1
Formula : C29H30F3N5O2
M.W : 537.58
SMILES Code : O=C(NC1=CC=C(CN2CCN(CC)CC2)C(C(F)(F)F)=C1)C3=CC=C(C)C(OC4=C5C(NC=C5)=NC=C4)=C3
MDL No. :MFCD19443255
InChI Key :SMPGEBOIKULBCT-UHFFFAOYSA-N
Pubchem ID :53340664

Safety of NG25

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of NG25

pyroptosis
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse primary myoblasts 1-10 μM 48 hours NG25 attenuated TGF-β1-induced TAK1 phosphorylation and inhibited the transdifferentiation of myoblasts into fibroblasts, reducing collagen I expression, while promoting myoblast differentiation, as indicated by increased myogenin expression and increased myosin heavy chain expression. PMC7890152

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice mdx mouse model Intraperitoneal injection 6 mg/kg/day Once daily for 2 weeks NG25 treatment improved muscle function in mdx mice, reducing fibrosis and muscle atrophy, as evidenced by increased muscle strength, decreased serum CK and LDH levels, and inhibition of TAK1 phosphorylation. PMC7890152

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.86mL

0.37mL

0.19mL

9.30mL

1.86mL

0.93mL

18.60mL

3.72mL

1.86mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories